In our case, the remission has solved our problem, but the problem is that, when they ship into the States, some of the product that they make is being hit under the 232 duty. On the Canadian side of their business, they're impacted by foreign product that's not subject at all to any duties, so they're now the high-cost producer.
On November 1st, 2018. See this statement in context.